SEARCH

SEARCH BY CITATION

REFERENCES

  • 1)
    Hori , K. , Suzuki , M. , Tanda , S. and Saito , S. Characterization of heterogeneous distribution of tumor blood flow in the rat . Jpn. J. Cancer Res. , 82 , 109117 ( 1991 ).
  • 2)
    Hori , K. , Suzuki , M. , Tanda , S. , Saito , S. , Shinozaki , M. and Zhang , Q.-H. Circadian variation of tumor blood flow in rat subcutaneous tumors and its alteration by angiotensin II-induced hypertension . Cancer Res. , 52 , 912916 ( 1992 ).
  • 3)
    Jain , R. K. Transport of molecules in the tumor interstitium: a review . Cancer Res. , 47 , 30393051 ( 1987 ).
  • 4)
    Horsman , M. R. , Chaplin , D. J. and Overgaard , J. The use of blood flow modifiers to improve the treatment response of solid tumors . Radiother. Oncol. , 20 ( Suppl. ), 4752 ( 1991 ).
  • 5)
    Suzuki , M. , Hori , K. , Abe , I. , Saito , S. and Sato , H. Anew approach to cancer chemotherapy: selective enhancement of tumor blood flow with Angiotensin II . J. Natl. Cancer Inst. , 67 , 663669 ( 1981 ).
  • 6)
    Carswell , E. A. , Old , L. J. , Kassel , R. L. , Green , S. , Fiore , N. and Williamson , B. An endotoxin-induced serum factor which causes necrosis of tumors . Proc. Natl. Acad. Sci. USA , 72 , 36663670 ( 1975 ).
  • 7)
    Mahadevan , V. , Malik , S. T. A. , Meager , A. , Fiers , W. , Lewis , G. P. and Hart , I. R. Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown . Cancer Res. , 50 , 55375542 ( 1990 ).
  • 8)
    Pratesi , G. , Rodolfo , M. , Rovetta , G. and Parmiani , G. Role of T cells and tumor necrosis factor in antitumor activity and toxicity of flavon acetic acid . Eur. J. Cancer , 26 , 10791083 ( 1990 ).
  • 9)
    Yang , D. , Satoh , M. , Ueda , H. , Tsukagoshi , S. and Yamazaki , M. Activation of tumor-infiltrating macro-phages by a synthetic lipid A analog (ONO-4007. and its implication in antitumor effects . Cancer Immunol. Immunother. , 38 , 287293 ( 1994 ).
  • 10)
    Dvorak , H. F. and Gresser , I. Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumor in mice . J. Natl. Cancer Inst. , 81 , 497502 ( 1989 ).
  • 11)
    Belardelli , F. , Proietti , E. , Ciolli , V. , Sestili , P. , Carpinelli , G. , Vito , M. D. , Ferretti , A. , Woodrow , D. , Boraschi , D. and Podo , F. Interleukin-1 beta induces tumor necrosis and early morphologic and metabolic changes in transplantable mouse tumors. Similarities with the anti-tumor effects of tumor necrosis factor alpha or beta . Int. J. Cancer , 44 , 116123 ( 1989 ).
  • 12)
    Yanase , T. , Tamura , M. , Fujita , K. , Kodama , S. and Tanaka , K. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo . Cancer Res. , 53 , 25662570 ( 1993 ).
  • 13)
    Yamaoka , M. , Yamamoto , T. , Masaki , T. , Ikeyama , S. , Sudo , K. and Fujita , T. Inhibition of tumor and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloro-acetyl-carbamoyl)fumagillol (TNP-470; AGM-1470) . Cancer Res. , 53 , 42624267 ( 1993 ).
  • 14)
    Gutterman , J. and Kavanagh , J. A phase I study of the toxicity, pharmacokinetics, and activity of TNP-470 administered to patients with advanced or recurrent squamous cell cancer of the cervix . Proc. Am. Soc. Clin. Oncol. , 14 , 281 ( 1995 ).
  • 15)
    Fotsis , T. , Zhang , Y. , Pepper , M. S. , Adlercreutz , H. , Montesano , R. , Nawroth , P. P. and Schweigerer , L. The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumor growth . Nature , 368 , 237239 ( 1994 ).
  • 16)
    Boehm , T. , Folkman , J. , Browder , T. and O'Reilly , M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance . Nature , 390 , 404407 ( 1997 ).
  • 17)
    O'Reilly , M. S. , Holmgren , L. , Chen , C. and Folkman , J. Angiostatin induces and sustains dormancy of human primary tumors in mice . Nat. Med. , 2 , 689692 ( 1996 ).
  • 18)
    Sim , B. K. L. , O'Reilly , M. S. , Liang , H. , Fortier , A. H. , He , W. , Madsen , J. W. , Lapcevich , R. and Nacy , C. A. A recombinant human Angiostatin protein inhibits experimental primary and metastatic cancer . Cancer Res. , 57 , 13291334 ( 1997 ).
  • 19)
    Hieber , U. and Heim , M. E. Tumor necrosis factor for the treatment of malignancies . Oncology , 51 , 142153 ( 1994 ).
  • 20)
    Feinberg , B. , Kurzorck , R. , Talpaz , M. , Blick , M. , Saks , S. and Gutterman , J. U. Phase I trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients . J. Clin. Oncol. , 6 , 13281334 ( 1988 ).
  • 21)
    Kerr , D. J. , Maughan , T. , Newlands , E. , Rustin , G. , Bleehen , N. M. , Lewis , C. and Kaye , S. B. Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma . Br. J. Cancer , 60 , 104106 ( 1989 ).
  • 22)
    Siegenthaler , P. , Kaye , S. B. , Monfardini , S. and Renard , J. Phase II trial with flavon acetic acid (NSC. 347512, LM975. in patients with non-small cell lung cancer . Ann. Oncol. , 3 , 169170 ( 1992 ).
  • 23)
    Gradisher , W. J. An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action . Invest. New Drugs , 15 , 4959 ( 1997 ).
  • 24)
    Pluda , J. M. , Wyvill , K. , Figg , W. D. , Whitcup , S. M. , Lietzau , J. , Saville , M. W. , Cohen , R. , Feigal , E. , Parks , D. , Foli , A. , Bailey , J. , Broder , S. and Yarchoan , R. A phase I study of an angiogenesis inhibitor, TNP-470 (AGM-1470), administered to patients with HIV-associated Kaposi's sarcoma . Proc. Am. Soc. Clin. Oncol. , 13 , 51 ( 1994 ).
  • 25)
    Zukiwski , A. , Gutterman , J. , Bui , C. , Sella , A. , Ellerhorst , J. , Tu , S. , Amato , R. , Figg , W. , Kilboum , R. and Logothetis , C. Phase I trial of the angiogenesis inhibitor TNP-470 (AGM-1470. in patients with androgen independent prostate cancer . Proc. Am. Soc. Clin. Oncol. , 13 , 252 ( 1994 ).
  • 26)
    Kudelka , A. , Edwards , C. , Freedman , R. , Girtanner , R. , Kaplan , A. , Fishman , A. , Balat , O. , Tresukosol , D. , De Leon , C. G. , Hord , M. , Finnegan , M. , Calayag , M. , Hunter , C. , Gutterman , J. and Kavanagh , J. A phase I study of the toxicity, pharmacokinetics, and activity of TNP-470 administered to patients with advanced or recurrent squamous cell cancer of the cervix . Proc. Am. Soc. Clin. Oncol. , 14 , 281 ( 1995 ).
  • 27)
    Chaplin , D. J. , Pettit , G. R. , Parkins , C. S. and Hill , S. A. Antivascular approaches to solid tumor therapy: evaluation of tubulin binding agents . Br. J. Cancer , 74 ( Suppl. XXVII ), S86S88 ( 1996 ).
  • 28)
    Hill , S. A. , Sampson , L. E. and Chaplin , D. J. Anti-vascular approaches to solid tumor therapy: evaluation of Vinblastine and flavone acetic acid . Int. J. Cancer , 63 , 119123 ( 1995 ).
  • 29)
    Dark , G. G. , Hill , S. A. , Prise , V. E. , Tozer , G. M. , Pettit , G. R. and Chaplin , D. J. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature . Cancer Res. , 10 , 18291834 ( 1997 ).
  • 30)
    Nihei , Y. , Suzuki , M. , Okano , A. , Tsuji , T. , Akiyama , Y. , Saito , S. , Hori , K. and Sato , Y. Anti-vascular effects of AC-7700 on solid tumors; comparison with other tubulin binding agents . Proc. Am. Assoc. Cancer Res. , 39 , 324 ( 1998 ).
  • 31)
    Ohsumi , K. , Nakagawa , R. , Fukuda , Y. , Hatanaka , T. , Morinaga , Y. , Nihei , Y. , Ohishi , K. , Suga , Y. , Akiyama , Y. and Tsuji , T. Novel combretastatin analogues effective against murine solid tumors; design and structure-activity relationships . J. Med. Chem. , 41 , 30223032 ( 1998 ).
  • 32)
    Nihei , Y. , Suga , Y. , Morinaga , Y. , Ohishi , K. , Suzuki , M. , Okano , A. , Ohsumi , K. , Nakagawa , R. , Tsuji , T. , Akiyama , Y. and Tsuruo , T. A novel combretastatin-A4 derivative AC-7700 shows marked antitumor activity against advanced solid tumors . Proc. Am. Assoc. Cancer Res. , 39 , 1143 ( 1998 ).
  • 33)
    Huang , X. , Molema , G. , King , S. , Watkins , L. , Edgington , T. S. and Thorpe , P. E. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature . Science , 275 , 547550 ( 1997 ).
  • 34)
    Denekamp , J. , Hill , S. A. and Hobson , B. Vascular occlusion and tumor cell death . Eur. J. Cancer Clin. Oncol. , 19 , 271275 ( 1983 ).
  • 35)
    Yamamura , H. and Sato , H. Quantitative studies on the developing vascular system of rat hepatoma . J. Natl. Cancer Inst. , 53 , 12291240 ( 1974 ).
  • 36)
    Field , S. B. , Needham , S. , Burney , I. A. , Maxwell , R. J. , Coggle , J. E. and Griffiths , J. R. Differences in vascular response between primary and transplanted tumors . Br. J. Cancer , 63 , 723726 ( 1991 ).
  • 37)
    Fu , X. , Besterman , J. M. , Monosov , A. and Hoffman , R. M. Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens . Proc. Natl. Acad. Sci. USA , 88 , 93459349 ( 1991 ).
  • 38)
    Togo , S. , Shimada , H. , Kubota , T. , Moossa , A. R. and Hoffman , R. M. Host organ specifically determines cancer progression . Cancer Res. , 55 , 681684 ( 1995 ).
  • 39)
    Bibby , M. C. , Phillips , R. M. , Double , J. A. and Pratesi , G. Anti-tumor activity of flavone acetic acid (NSC 347512. in mice – influence of immune status . Br. J. Cancer , 63 , 5762 ( 1991 ).
  • 40)
    Ching , L.-M. , Joseph , W. R. and Baguley , B. C. Antitumor responses to flavone-8-acetic acid and 5, 6-dimethylxan-thenone-4-acetic acid in immune deficient mice . Br. J. Cancer , 66 , 128130 ( 1992 ).
  • 41)
    Baguley , B. C. , Holdaway , K. M. , Thomsen , L. L. , Zhuang , L. and Zwi , L. J. Inhibition of growth of colon38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism . Eur. J. Cancer , 27 , 482487 ( 1991 ).